Christopher Cubitt

2.2k total citations
57 papers, 1.7k citations indexed

About

Christopher Cubitt is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Christopher Cubitt has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Molecular Biology and 17 papers in Hematology. Recurrent topics in Christopher Cubitt's work include Multiple Myeloma Research and Treatments (10 papers), Polyomavirus and related diseases (6 papers) and Ubiquitin and proteasome pathways (6 papers). Christopher Cubitt is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Polyomavirus and related diseases (6 papers) and Ubiquitin and proteasome pathways (6 papers). Christopher Cubitt collaborates with scholars based in United States, France and Italy. Christopher Cubitt's co-authors include John E. Oakes, Robert N. Lausch, Carlos Augusto Monteiro, Daniel M. Sullivan, Michael Spector, Qizhi Tang, Jana L. Dawson, Jade Homsi, Adil Daud and Joel G. Turner and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher Cubitt

54 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Cubitt United States 26 691 500 277 216 210 57 1.7k
Barbara Boone Belgium 15 582 0.8× 401 0.8× 423 1.5× 110 0.5× 123 0.6× 24 1.6k
Michael J. Mitten United States 16 1.9k 2.7× 832 1.7× 322 1.2× 141 0.7× 141 0.7× 27 2.8k
Valérie Gouyer France 28 1.2k 1.7× 632 1.3× 392 1.4× 114 0.5× 113 0.5× 52 2.1k
Dorothy Hudig United States 28 1.1k 1.5× 518 1.0× 1.1k 3.9× 128 0.6× 160 0.8× 79 2.4k
Kyoko Yokota Japan 12 995 1.4× 356 0.7× 575 2.1× 45 0.2× 204 1.0× 46 2.0k
Jacques Bara France 30 1.2k 1.8× 456 0.9× 554 2.0× 340 1.6× 507 2.4× 107 2.6k
T. Jesse Kwoh United States 22 1.3k 1.9× 294 0.6× 380 1.4× 81 0.4× 90 0.4× 41 2.4k
Isabelle Rooney United States 25 1.0k 1.5× 618 1.2× 1000 3.6× 124 0.6× 119 0.6× 49 2.5k
Melanie Planyavsky Austria 12 1.3k 1.9× 246 0.5× 964 3.5× 110 0.5× 107 0.5× 14 2.2k
R. Michael Sramkoski United States 23 842 1.2× 294 0.6× 405 1.5× 127 0.6× 52 0.2× 42 1.6k

Countries citing papers authored by Christopher Cubitt

Since Specialization
Citations

This map shows the geographic impact of Christopher Cubitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Cubitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Cubitt more than expected).

Fields of papers citing papers by Christopher Cubitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Cubitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Cubitt. The network helps show where Christopher Cubitt may publish in the future.

Co-authorship network of co-authors of Christopher Cubitt

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Cubitt. A scholar is included among the top collaborators of Christopher Cubitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Cubitt. Christopher Cubitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giuliano, Anna R., Barbara J. Kuter, Shari Pilon‐Thomas, et al.. (2023). Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients. Cancer Communications. 43(7). 749–764. 6 indexed citations
2.
Hensel, Jonathan A., Christopher Cubitt, Michael J. Schell, et al.. (2023). SARS-CoV-2 antibody response duration and neutralization following natural infection. SHILAP Revista de lepidopterología. 3(3). 100158–100158.
3.
Turner, Joel G., Yan Cui, Jana L. Dawson, et al.. (2020). Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma. Cancer Research. 80(23). 5344–5354. 15 indexed citations
4.
Shain, Kenneth H., Rafael Renatino Canevarolo, Mark B. Meads, et al.. (2020). Characterization of Synergistic Selinexor Combinations of Dexamethasone, Pomalidomide, Elotuzumab and Daratumumab in Primary MM Samples Ex Vivo. Blood. 136(Supplement 1). 29–30. 1 indexed citations
5.
Sweet, Kendra, Rami S. Komrokji, Eric Padron, et al.. (2019). Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia. Clinical Cancer Research. 26(1). 54–60. 22 indexed citations
6.
7.
Extermann, Martine, Christiaan Leeuwenburgh, Laila Samiian, et al.. (2016). Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. Journal of Geriatric Oncology. 8(1). 69–75. 14 indexed citations
8.
Bush, Stephen, Douglas C. Marchion, Yin Xiong, et al.. (2016). Sensitivity of ovarian cancer cells to acetaminophen reveals biological pathways that affect patient survival. Molecular and Clinical Oncology. 4(3). 399–404. 7 indexed citations
9.
10.
Kahen, Elliot, Diana Yu, Douglas J. Harrison, et al.. (2016). Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma. Cancer Chemotherapy and Pharmacology. 78(2). 313–323. 17 indexed citations
11.
Yang, Hua, Michael F. Emmons, Christopher Cubitt, et al.. (2015). Abstract 2605: The geranylgeranyltransferase I inhibitor GGTI-2418 suppresses multiple myeloma malignancy in the 5TMG1 mouse model. Cancer Research. 75(15_Supplement). 2605–2605. 1 indexed citations
12.
Turner, Joel G., Jana L. Dawson, Christopher Cubitt, Rachid Baz, & Daniel M. Sullivan. (2014). Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents. Seminars in Cancer Biology. 27. 62–73. 74 indexed citations
13.
Almhanna, Khaldoun, Christopher Cubitt, Shumin Zhang, et al.. (2013). MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines. Cancer Biology & Therapy. 14(10). 932–936. 26 indexed citations
14.
Turner, Joel G., Jana L. Dawson, Michael F. Emmons, et al.. (2013). CRM1 Inhibition Sensitizes Drug Resistant Human Myeloma Cells to Topoisomerase II and Proteasome Inhibitors both In Vitro and Ex Vivo. Journal of Cancer. 4(8). 614–625. 59 indexed citations
15.
Gray, Jhanelle E., Christopher Cubitt, Shumin Zhang, & Alberto Chiappori. (2012). Combination of HDAC and topoisomerase inhibitors in small cell lung cancer. Cancer Biology & Therapy. 13(8). 614–622. 44 indexed citations
16.
Biçaku, Elona, Yin Xiong, Hye Sook Chon, et al.. (2012). In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival. British Journal of Cancer. 106(12). 1967–1975. 32 indexed citations
17.
Garrett, Christopher R., Domenico Coppola, Robert M. Wenham, et al.. (2010). Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT. Investigational New Drugs. 29(6). 1381–1389. 67 indexed citations
18.
Cubitt, Christopher. (2007). Molecular Genetics of the BK Virus. Advances in experimental medicine and biology. 577. 85–95. 34 indexed citations
19.
Homsi, Jade, Christopher Cubitt, & Adil Daud. (2006). The Src signaling pathway: a potential target in melanoma and other malignancies. Expert Opinion on Therapeutic Targets. 11(1). 91–100. 62 indexed citations
20.
Drachenberg, Cinthia B., John C. Papadimitriou, Ravinder K. Wali, Christopher Cubitt, & Emilio Ramos. (2003). BK Polyoma Virus Allograft Nephropathy: Ultrastructural Features from Viral Cell Entry to Lysis. American Journal of Transplantation. 3(11). 1383–1392. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Boone Breakdown of academic impact, for papers by Michael J. Mitten Breakdown of academic impact, for papers by Valérie Gouyer Breakdown of academic impact, for papers by Dorothy Hudig Breakdown of academic impact, for papers by Kyoko Yokota Breakdown of academic impact, for papers by Jacques Bara Breakdown of academic impact, for papers by T. Jesse Kwoh Breakdown of academic impact, for papers by Isabelle Rooney Breakdown of academic impact, for papers by Melanie Planyavsky Breakdown of academic impact, for papers by R. Michael Sramkoski
Rankless by CCL
2026